Currently out of the existing stock ratings of Zhiqiang Shu, 18 are a BUY (72%), 7 are a HOLD (28%).

Zhiqiang Shu

Work Performance Price Targets & Ratings Chart

Analyst Zhiqiang Shu, currently employed carries an average stock price target met ratio of 33.33% that have a potential upside of 11.78% achieved within 46 days. Previously, Zhiqiang Shu worked at BERENBERG.

Zhiqiang Shu’s has documented 44 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.

Wall Street Analyst Zhiqiang Shu

Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/12/2021. The price target of $11 was fulfilled within 6 days with a profit of $0.68 (5.82%) receiving and performance score of 9.7.

Average potential price target upside

of $33.79 (68.43%) on BPMC (BLUEPRINT MEDICINES CORP).
of $31.99 (23.18%) on SGEN (SEAGEN).

BLUE Bluebird bio SNSE Sensei Biotherapeutics STRO Sutro Biopharma BPMC Blueprint Medicines Corp PNT POINT Biopharma Global KRON Kronos Bio SGEN Seagen AFMD Affimed NV SRPT Sarepta Therapeutics

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Yanan Zhu (WELLS FARGO)